AxoGen, Inc. Contracts & Agreements

First Amendment to Lease Agreement, dated as of August 22, 2022, by and between Axogen Corporation and Ja-Cole, L.P (Filed With SEC on August 25, 2022)

Eighth Amendment to License and Services Agreement, dated as of August 22, 2022, by and between Axogen Corporation and Community Blood Center (d/b/a Community Tissue Services) (Filed With SEC on August 25, 2022)

Form of Performance-Based Restricted Stock Units Notice and Performance-Based Restricted Stock Units Agreement under the Axogen, Inc. Amended and Restated 2019 Long-Term Incentive... (Filed With SEC on April 1, 2022)

Form of Restricted Stock Units Notice and Restricted Stock Units Agreement under the Axogen, Inc. Amended and Restated 2019 Long-Term Incentive Plan (Filed With SEC on April 1, 2022)

Form of Incentive Stock Option Notice and Incentive Stock Option Agreement under the Axogen, Inc. Amended and Restated 2019 Long-Term Incentive Plan (Filed With SEC on April 1, 2022)

Form of Premium Incentive Stock Option Notice and Premium Incentive Stock Option Notice Agreement under the Axogen, Inc. Amended and Restated 2019 Long-Term Incentive Plan (Filed With SEC on April 1, 2022)

Commercial Lease Amendment, dated as of January 27, 2022, by and between Axogen Corporation and Ja-Cole, L.P (Filed With SEC on January 31, 2022)

First Amendment to Office Lease, dated as of July (Filed With SEC on July 16, 2021)

Sixth Amendment to Lease, dated as of July 1 (Filed With SEC on July 16, 2021)

Seventh Amendment to License and Services Agreement, dated as of February 22, 2021, by and between Axogen Corporation and Community Blood Center (d/b/a Community Tissues Services) (Filed With SEC on February 26, 2021)

Second Amended and Restated Employment Agreement, effective January 4, 2021, between Axogen Corporation and Angelo Scopelianos (Filed With SEC on January 6, 2021)

Fifth Amendment to Lease, dated as of November 30, 2020, by and between AxoGen Corporation and SNH Medical Office Properties Trust (Filed With SEC on December 4, 2020)

Commercial Lease, dated October 1, 2020, by and between Axogen Corporation and Ja-Cole, L.P (Filed With SEC on October 30, 2020)

Amended and Restated Employment Agreement, dated November 1, 2020, by and between Axogen Corporation and Karen Zaderej (Filed With SEC on October 29, 2020)

Amended and Restated Employment Agreement, dated November 1, 2020, by and between Axogen Corporation and Peter Mariani (Filed With SEC on October 29, 2020)

Amended and Restated Employment Agreement, dated November 1, 2020, by and between Axogen Corporation and Eric Sandberg (Filed With SEC on October 29, 2020)

Amended and Restated Employment Agreement, dated November 1, 2020, by and between Axogen Corporation and Maria Martinez (Filed With SEC on October 29, 2020)

Amended and Restated Employment Agreement, dated November 1, 2020, by and between Axogen Corporation and Isabelle Billet (Filed With SEC on October 29, 2020)

Amended and Restated Employment Agreement, dated November 1, 2020, by and between Axogen Corporation and Bradley Ottinger (Filed With SEC on October 29, 2020)

Amended and Restated Employment Agreement, dated November 1, 2020, by and between Axogen Corporation and Angelo Scopelianos (Filed With SEC on October 29, 2020)

Term Loan Agreement, dated June 30, 2020, among Axogen, Inc., Axogen Corporation, AxoGen Processing Corporation, TPC Investments II LP and Argo SA LLC (Filed With SEC on July 1, 2020)

Security Agreement, dated June 30, 2020, among Axogen, Inc., Axogen Corporation, AxoGen Processing Corporation, and Argo SA LLC (Filed With SEC on July 1, 2020)

Revenue Participation Agreement, dated June 30, 2020, between Axogen, Inc. and Argo SA LLC (Filed With SEC on July 1, 2020)

Option Agreement, dated June 30, 2020, between Axogen, Inc. and TPC Investments II LP (Filed With SEC on July 1, 2020)

Executive Employment Agreement, dated as of June 1, 2020, by and between Axogen Corporation and Brad Ottinger (Filed With SEC on June 1, 2020)

Amendment No. 5 to Employment Agreement, dated as of June 1, 2020, by and between Greg Freitag and Axogen, Inc (Filed With SEC on June 1, 2020)

Description of Securities of Axogen, Inc (Filed With SEC on February 24, 2020)

Nerve End Cap Supply Agreement, dated June 27, 2017, by and between Cook Biotech Incorporated and Axogen Corporation (Filed With SEC on February 24, 2020)

Axogen Inc. 2019 Long-Term Incentive Plan and forms of award notices and agreements thereunder (Filed With SEC on November 6, 2019)

Commercial Lease Amendment 4, dated March 12, 2019, by and between Ja-Cole L.P. and Axogen Corporation (Filed With SEC on May 8, 2019)

Fourth Amendment to License and Services Agreement, dated as of February 22, 2019, by and between Axogen Corporation and Community Blood Center (d/b/a Community Tissue Services) (Filed With SEC on February 26, 2019)

Form of Performance Stock Unit Award Agreement pursuant to the Axogen, Inc. 2010 Stock Incentive Plan, as amended and restated as of April 5, 2017 (Filed With SEC on February 26, 2019)

Executive Employment Agreement dated as of January 21, 2019, by and between AxoGen Corporation and Eric Sandberg (Filed With SEC on January 22, 2019)

Form of Non-Qualified Stock Option Inducement Award Agreement to be granted by AxoGen, Inc. to Eric Sandberg on January 22, 2019 (Filed With SEC on January 22, 2019)

Separation Agreement and General Release, dated January 18, 2019, between AxoGen Corporation and Shawn McCarrey (Filed With SEC on January 18, 2019)

Separation Agreement and General Release, dated January 15, 2019, between AxoGen Corporation and Jon Gingrich (Filed With SEC on January 16, 2019)

Commercial Lease Amendment 3 dated November21, 2018 by and between Ja-ColeL.P. and AxoGen Corporation (Filed With SEC on November 26, 2018)

Lease, dated November19, 2018 by and between SNH Medical Office Properties Trust and AxoGen Corporation (Filed With SEC on November 26, 2018)

First Amendment to Lease dated as of November19, 2018 by and between SNH Medical Office Properties Trust and AxoGen Corporation (Filed With SEC on November 26, 2018)

Agreement of Lease dated October 26, 2018, by and between Ashley Avenue Associates I, LLC and AxoGen Corporation (Filed With SEC on October 29, 2018)

Executive Employment Agreement, dated as of October 29, 2018, by and between AxoGen Corporation and Isabelle Billet (Filed With SEC on October 29, 2018)

Form of Incentive Stock Option Agreement pursuant to the AxoGen, Inc. 2010 Stock Incentive Plan, as amended and restated as of October 29, 2018 (Filed With SEC on October 29, 2018)

Form of Restricted Stock Unit Award Agreement pursuant to the AxoGen, Inc. 2010 Stock Incentive Plan, as amended and restated as of October 29, 2018 (Filed With SEC on October 29, 2018)

Amendment No. 4 to Employment Agreement, dated as of October 29, 2018, by and between Greg Freitag and AxoGen, Inc (Filed With SEC on October 29, 2018)

Executive Employment Agreement, dated as of October 29, 2018, by and between AxoGen Corporation and Maria Martinez (Filed With SEC on October 29, 2018)

Letter Agreement effective September 20, 2018 by between AxoGen Corporation and SNH Medical Office Properties Trust (Filed With SEC on September 21, 2018)

Office Lease dated September 20, 2018 by and between AxoGen Corporation and Heights Union, LLC (Filed With SEC on September 21, 2018)

Executive Employment Agreement dated September 4, 2018, by and between AxoGen Corporation and Angelo Scopelianos (Filed With SEC on September 7, 2018)

Agreement For Purchase and Sale of Real Property ARC CRVANOH001, LLC and AXOGEN CORPORATION dated June 6, 2018 (Filed With SEC on July 12, 2018)

Underwriting Agreement by and among the Company, Jefferies LLC and Leerink Partners LLC, as representatives of the underwriters named therein, dated May 8, 2018 (Filed With SEC on May 14, 2018)

Current Premises Election Notice dated as of April 10, 2018 (Filed With SEC on April 13, 2018)

Registration Rights Agreement, dated as of August 26, 2015, between AxoGen, Inc. and Essex Woodlands Fund IX, L.P (Filed With SEC on February 28, 2018)

Amended Form of Employee Incentive Stock Option Agreement pursuant to the AxoGen, Inc. 2010 Stock Incentive Plan, as amended and restated as of March 23, 2016 (Filed With SEC on February 28, 2018)

Form of 2018 Performance Stock Unit Award Agreement pursuant to the AxoGen, Inc. 2010 Stock Incentive Plan, as amended and restated as of March 23, 2016 (Filed With SEC on February 28, 2018)

Form of Restricted Stock Unit Award Agreement pursuant to the AxoGen, Inc. 2010 Stock Incentive Plan, as amended and restated as of March 23, 2016 (Filed With SEC on February 28, 2018)

Amendment No. 2 to Distribution Agreement, dated as of February 26, 2018, by and between AxoGen, Inc. and Cook Biotech Incorporated (Filed With SEC on February 28, 2018)

Underwriting Agreement by and among the Company, EW Healthcare Partners L.P. and Leerink Partners LLC, as representative of the underwriters named therein, dated November 16, 2017 (Filed With SEC on November 21, 2017)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on July 20, 2017)

AXOGEN, INC. NON–QUALIFIED STOCK OPTION INDUCEMENT AWARD AGREEMENT (Filed With SEC on July 20, 2017)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on July 18, 2017)

AXOGEN, INC. NON–QUALIFIED STOCK OPTION INDUCEMENT AWARD AGREEMENT (Filed With SEC on July 18, 2017)

AXOGEN, INC. INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on March 1, 2017)

LEASE BY AND BETWEEN SNH MEDICAL OFFICE PROPERTIES TRUST LANDLORD AND AXOGEN CORPORATION TENANT Progress Center 13709 Progress Boulevard Alachua, FL 32615 (Filed With SEC on January 26, 2017)

TEXAS ASSOCIATION OF REALTORS® Commercial Lease Amendment 2 USE OF THIS FORM BY PERSONS WHO ARE NOT MEMBERS OF THE TEXAS ASSOCIATION OF REALTORS® IS NOT AUTHORIZED. ©Texas... (Filed With SEC on October 31, 2016)

2,333,334 Shares AxoGen, Inc. Common Stock ($0.01 par value) Underwriting Agreement (Filed With SEC on October 13, 2016)

SECOND AMENDMENT TO THE AMENDED AND RESTATED STANDARD EXCLUSIVE LICENSE AGREEMENT NO. A5140 (Filed With SEC on July 11, 2016)

AMENDMENT 1 TO TERM LOAN AGREEMENT (Filed With SEC on July 6, 2016)

Amendment NO. 3 To Employment AGreement (Filed With SEC on May 31, 2016)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on May 4, 2016)

FOURTH AMENDMENT TO LEASE (Filed With SEC on March 18, 2016)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 14, 2016)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 5, 2015)

DEVELOPMENT, LICENSE & OPTION AGREEMENT (Filed With SEC on November 5, 2015)

LICENSE AND SERVICES AGREEMENT (Filed With SEC on November 5, 2015)

Amendment NO. 2 To Employment AGreement (Filed With SEC on November 5, 2015)

TEXAS ASSOCIATION OF REALTORS COMMERCIAL LEASE USE OF THIS FORM BY PERSONS WHO ARE NOT MEMBERS OF THE TEXAS ASSOCIATION OF REALTORS IS NOT AUTHORIZED. Texas Association of... (Filed With SEC on April 22, 2015)

TEXAS ASSOCIATION OF REALTORS COMMERCIAL LEASEHOLD CONSTRUCTION ADDENDUM (Tenant to Complete Construction) USE OF THIS FORM BY PERSONS WHO ARE NOT MEMBERS OF THE TEXAS ASSOCIATION... (Filed With SEC on April 22, 2015)

AXOGEN, INC. 4,728,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on February 5, 2015)

FOURTH AMENDMENT TO AMENDED AND RESTATED NERVE TISSUE PROCESSING AGREEMENT (Filed With SEC on November 13, 2014)

AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on August 4, 2014)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 4, 2014)

THIRD AMENDMENT TO LEASE (Filed With SEC on March 6, 2014)

[ ] Shares AxoGen, Inc. Common Shares ($0.01 par value) Underwriting Agreement dated[ ], 2013 (Filed With SEC on August 5, 2013)

REVENUE INTERESTS PURCHASE AGREEMENT Dated as of October 5, 2012 between AxoGen, Inc. and PDLBioPharma, Inc. Table of Contents (Filed With SEC on July 30, 2013)

GUARANTEE AND COLLATERAL AGREEMENT DATED AS OF OCTOBER 5, 2012 BY AXOGEN, INC., AND AXOGENCORPORATION, AS GRANTORS IN FAVOR OF PDL BIOPHARMA, INC., AS PURCHASER TABLE OF CONTENTS (Filed With SEC on July 30, 2013)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on April 30, 2013)

REVENUE INTERESTS PURCHASE AGREEMENT Dated as of October 5, 2012 between AxoGen, Inc. and PDLBioPharma, Inc. Table of Contents (Filed With SEC on March 12, 2013)

GUARANTEE AND COLLATERAL AGREEMENT DATED AS OF OCTOBER 5, 2012 BY AXOGEN, INC., AND AXOGENCORPORATION, AS GRANTORS IN FAVOR OF PDL BIOPHARMA, INC., AS PURCHASER TABLE OF CONTENTS (Filed With SEC on March 12, 2013)

SECOND AMENDMENT TO LEASE (Filed With SEC on March 12, 2013)

INTERIM REVENUE INTERESTSPURCHASE AGREEMENT Dated as of August 14, 2012 between AxoGen, Inc. and PDLBioPharma, Inc. Table of Contents (Filed With SEC on November 6, 2012)

SUBORDINATION AND INTERCREDITOR AGREEMENT (Filed With SEC on November 6, 2012)

FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on November 6, 2012)

THIRD AMENDMENT TO AMENDED AND RESTATED NERVE TISSUE PROCESSING AGREEMENT (Filed With SEC on March 15, 2012)

AMENDMENT NO. 1 TO DISTRIBUTION AGREEMENT (Filed With SEC on March 15, 2012)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 15, 2012)

FIRST AMENDMENT TO LEASE (Filed With SEC on March 15, 2012)

AXOGEN AMENDED AND RESTATED NERVE TISSUE PROCESSING AGREEMENT (Filed With SEC on January 25, 2012)

LEASE (Filed With SEC on November 14, 2011)

PATENT LICENSE AGREEMENT (Filed With SEC on October 6, 2011)

AMENDED AND RESTATED STANDARD EXCLUSIVE LICENSE AGREEMENT WITH SUBLICENSINGTERMS (Filed With SEC on October 6, 2011)

Sid Martin Biotechnology Development Institute INCUBATOR LICENSE AGREEMENT (Filed With SEC on October 6, 2011)

AXOGEN AMENDED AND RESTATED NERVE TISSUE PROCESSING AGREEMENT (Filed With SEC on October 6, 2011)

SECOND AMENDMENT TO AMENDED AND RESTATED NERVE TISSUE PROCESSING AGREEMENT (Filed With SEC on October 6, 2011)

DISTRIBUTION AGREEMENT (Filed With SEC on October 6, 2011)

LOAN AND SECURITY AGREEMENT (Filed With SEC on October 6, 2011)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on October 6, 2011)

AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on October 6, 2011)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on October 6, 2011)

AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on October 6, 2011)

SHARE TRANSFER RESTRICTION AGREEMENT (Filed With SEC on July 6, 2011)

SETTLEMENT AGREEMENT AND MUTUAL RELEASE (Filed With SEC on July 6, 2011)

SUBORDINATED SECURED CONVERTIBLE PROMISSORY NOTE (the Note) (Filed With SEC on July 6, 2011)

STOCK PURCHASE AGREEMENT (Filed With SEC on July 6, 2011)

AGREEMENT AND PLAN OF MERGER BY AND AMONG LECTEC CORPORATION, NERVE MERGER SUB CORP. AND AXOGEN CORPORATION DATED AS OF MAY 31, 2011 (Filed With SEC on June 2, 2011)

VOTING AGREEMENT (Filed With SEC on June 2, 2011)

SUBORDINATED SECURED CONVERTIBLE PROMISSORY NOTE (the Note) $2,000,000 Issue Date: May 31, 2011 (Filed With SEC on June 2, 2011)

SECURITY AGREEMENT (Filed With SEC on June 2, 2011)

CONDENSED FINANCIAL STATEMENTS AND NOTES TO CONDENSED FINANCIAL STATEMENTS (Filed With SEC on May 17, 2011)

PATENT PURCHASE AGREEMENT (Filed With SEC on May 13, 2011)

CURRENT ASSETS (Filed With SEC on November 15, 2010)

ADVISORYSERVICES AGREEMENT (Filed With SEC on June 2, 2010)

LECTECCORPORATION NONQUALIFIEDSTOCK OPTION AGREEMENT (Filed With SEC on June 2, 2010)

SETTLEMENT AGREEMENT ANDMUTUAL RELEASE (Filed With SEC on March 31, 2010)

Term Sheet (Filed With SEC on November 12, 2009)

SETTLEMENT AND LICENSE AGREEMENT (Filed With SEC on November 12, 2009)

CONDENSED FINANCIAL STATEMENTS AND NOTES TO CONDENSED FINANCIAL STATEMENTS (Filed With SEC on August 13, 2009)

SETTLEMENT AGREEMENT AND MUTUAL RELEASE (Filed With SEC on June 3, 2009)

SECOND AMENDMENT TO OFFICE/WAREHOUSE LEASE (Filed With SEC on January 23, 2009)

THIRD AMENDMENT TO OFFICE/WAREHOUSE LEASE (Filed With SEC on January 23, 2009)

Lease Amendment (Filed With SEC on August 14, 2008)

Lease Agreement (Filed With SEC on August 14, 2008)

Category

Industry

Companies

Contracts

AxoGen, Inc. Contracts & Agreements